↓ Skip to main content

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration

Overview of attention for article published in Cost Effectiveness and Resource Allocation, June 2008
Altmetric Badge

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
Published in
Cost Effectiveness and Resource Allocation, June 2008
DOI 10.1186/1478-7547-6-12
Pubmed ID
Authors

Susan F Hurley, Jane P Matthews, Robyn H Guymer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 5%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 27%
Student > Bachelor 6 14%
Student > Ph. D. Student 5 11%
Other 4 9%
Student > Master 4 9%
Other 9 20%
Unknown 4 9%
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Economics, Econometrics and Finance 10 23%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Nursing and Health Professions 2 5%
Engineering 2 5%
Other 6 14%
Unknown 5 11%